Intelligence quotient in paediatric sickle cell disease: a systematic review and meta-analysis

Developmental Medicine and Child Neurology

Volumn 58, Issue 7, 2016, Pages 672-679

  Kawadler, Jamie M ^a   Clayden, Jonathan D ^a   Clark, Chris A ^a   Kirkham, Fenella J ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN INFARCTION; CHILDHOOD; CONTROL GROUP; CONTROLLED STUDY; HUMAN; INFORMATION RETRIEVAL; INTELLIGENCE QUOTIENT; MEASUREMENT; MEDLINE; META ANALYSIS (TOPIC); NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; STROKE PATIENT; SYSTEMATIC REVIEW; WECHSLER INTELLIGENCE SCALE FOR CHILDREN;

EID: 84975145739     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.13113     Document Type: Review

References (84)

1. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91: 288–94.
2. DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood 2012; 119: 4587–96.
3. DWatkins KE, Hewes DK, Connelly A, et al. Cognitive deficits associated with frontal-lobe infarction in children with sickle cell disease. Dev Med Child Neurol 1998; 40: 536–43.
4. DeBaun MR, Schatz J, Siegel MJ, et al. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology 1998; 50: 1678–82.
5. Brown RT, Davis PC, Lambert R, Hsu L, Hopkins K, Eckman J. Neurocognitive functioning and magnetic resonance imaging in children with sickle cell disease. J Pediatr Psychol 2000; 25: 503–13.
6. Schatz J, Brown RT, Pascual JM, Hsu L, Debaun MR. Poor school performance and cognitive functioning with silent cerebral infarcts and sickle cell disease. Neurology 2001; 56: 1109–11.
7. Christ SE, Moinuddin A, McKinstry RC, DeBaun M, White DA. Inhibitory control in children with frontal infarcts related to sickle cell disease. Child Neuropsychol 2007; 13: 132–41.
8. Chordokoff J, Whitten CF. Intellectual status of children with sickle cell anemia. J Pediatr 1963; 63: 29–35.
9. Swift AV, Cohen MJ, Hynd GW, et al. Neuropsychologic impairment in children with sickle cell anemia. Pediatrics 1989; 84: 1077–85.
10. Hariman LM, Griffith ER, Hurtig AL, Keehn MT. Functional outcomes of children with sickle-cell disease affected by stroke. Arch Phys Med Rehabil 1991; 72: 498–502.
11. Wasserman ALL, Wilimas JAA, Fairclough DLL, Mulhern RKK, Wang W. Subtle neuropsychological deficits in children with sickle cell disease. Am J Pediatr Hematol Oncol 1991; 13: 14–20.
12. Knight S, Singhal A, Thomas P, Serjeant G. Factors associated with lowered intelligence in homozygous sickle cell disease. Arch Dis Child 1995; 73: 316–20.
13. Noll RB, Stith L, Gartstein MA, et al. Neuropsychological functioning of youths with sickle cell disease: comparison with non-chronically ill peers. J Pediatr Psychol 2001; 26: 69–78.
14. Hijmans CT, Fijnvandraat K, Grootenhuis MA, et al. Neurocognitive deficits in children with sickle cell disease: a comprehensive profile. Pediatr Blood Cancer 2011; 56: 783–88.
15. Armstrong FD, Thompson RJ, Wang W, et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics 1996; 97: 864–70.
16. Steen RG, Reddick WE, Mulhern RK, et al. Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI. J Magn Reson Imaging 1998; 8: 535–43.
17. Bernaudin F, Verlhac S, Freard F, et al. Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol 2000; 15: 333–43.
18. Wang W, Enos L, Gallagher D, et al. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001; 139: 391–97.
19. Steen RG, Miles MA, Helton KJ, et al. Cognitive impairment in children with hemoglobin SS sickle cell disease: relationship to MR imaging findings and hematocrit. AJNR Am J Neuroradiol 2003; 24: 382–89.
20. Baldeweg T, Hogan AM, Saunders DE, et al. Detecting white matter injury in sickle cell disease using voxel-based morphometry. Ann Neurol 2006; 59: 662–72.
21. Scantlebury N, Mabbott D, Janzen L, et al. White matter integrity and core cognitive function in children diagnosed with sickle cell disease. J Pediatr Hematol Oncol 2011; 33: 163–71.
22. Armstrong FD. Neurocognitive function in sickle cell disease: have we been missing something? Expert Rev Hematol 2010; 3: 519–21.
23. King AA, Strouse JJ, Rodeghier MJ, et al. Parent education and biologic factors influence on cognition in sickle cell anemia. Am J Hematol 2014; 89: 162–67.
24. Schatz J, Finke RL, Kellett JM, Kramer JH. Cognitive functioning in children with sickle cell disease: a meta-analysis. J Pediatr Psychol 2002; 27: 739–48.
25. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw 2010; 36: 1–48.
26. Gasparrini A, Armstrong B, Kenward MG. Multivariate meta-analysis for non-linear and other multi-parameter associations. Stat Med 2012; 31: 3821–39.
27. Wang WC, Gallagher DM, Pegelow CH, et al. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol 2000; 22: 335–39.
28. Kral MC, Brown RT, Connelly M, et al. Radiographic predictors of neurocognitive functioning in pediatric sickle cell disease. J Child Neurol 2006; 21: 37–44.
29. White DA, Moinuddin A, McKinstry RC, Noetzel M, Armstrong M, DeBaun M. Cognitive screening for silent cerebral infarction in children with sickle cell disease. J Pediatr Hematol Oncol 2006; 28: 166–69.
30. van der Land V, Hijmans CT, de Ruiter M, et al. Volume of white matter hyperintensities is an independent predictor of intelligence quotient and processing speed in children with sickle cell disease. Br J Haematol 2015; 168: 553–56.
31. Schatz J, Buzan R. Decreased corpus callosum size in sickle cell disease: relationship with cerebral infarcts and cognitive functioning. J Int Neuropsychol Soc 2006; 12: 24–33.
32. Schatz J, White DA, Moinuddin A, Armstrong M, DeBaun MR. Lesion burden and cognitive morbidity in children with sickle cell disease. J Child Neurol 2002; 17: 891–95.
33. Kawadler JM, Kirkham FJ, Clayden JD, et al. White matter damage relates to oxygen saturation in children with sickle cell anemia without silent cerebral infarcts. Stroke 2015; 46: 1793–99.
34. Steen RG, Fineberg-Buchner C, Hankins G, Weiss L, Prifitera A, Mulhern RK. Cognitive deficits in children with sickle cell disease. J Child Neurol 2005; 20: 102–07.
35. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101–29.
36. King A, Rodeghier M, Panepinto J, et al. Silent cerebral infarction, income and grade retention among students with sickle cell. Am J Hematol 2014; 89: 2–28.
37. Kwiatkowski JL, Zimmerman RA, Pollock AN, et al. Silent infarcts in young children with sickle cell disease. Br J Haematol 2009; 146: 300–05.
38. Pegelow C, Reed G, Moser F, Al E. Natural history of silent infarcts in children with sickle cell anemia (HbSS), abstract. Blood 1999; 94: 419A.
39. Pegelow CH. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 2002; 99: 3014–18.
40. Steen RG, Langston JW, Ogg RJ, Manci E, Mulhern RK, Wang W. Ectasia of the basilar artery in children with sickle cell disease: relationship to hematocrit and psychometric measures. J Stroke Cerebrovasc Dis 1998; 7: 32–43.
41. Strouse JJ, Cox CS, Melhem ER, et al. Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA). Blood 2006; 108: 379–81.
42. Steen RG, Xiong X, Mulhern RK, Langston JW, Wang WC. Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. Ann Neurol 1999; 45: 279–86.
43. Schatz J, Finke R, Roberts CW. Interactions of biomedical and environmental risk factors for cognitive development: a preliminary study of sickle cell disease. J Dev Behav Pediatr 2004; 25: 303–10.
44. Pollitt E. Iron deficiency and cognitive function. Annu Rev Nutr 1993; 13: 521–37.
45. Otero GA, Aguirre DM, Porcayo R, Fernández T. Psychological and electroencephalographic study in school children with iron deficiency. Int J Neurosci 1999; 99: 113–21.
46. Weiskopf RB, Feiner J, Hopf H, et al. Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology 2006; 104: 911–20.
47. Oguz KK, Golay X, Pizzini FB, et al. Sickle cell disease: continuous arterial spin-labeling perfusion MR imaging in children. Radiology 2003; 227: 567–74.
48. Gevers S, Nederveen AJ, Fijnvandraat K, et al. Arterial spin labeling measurement of cerebral perfusion in children with sickle cell disease. J Magn Reson Imaging 2012; 35: 779–87.
49. Hales PW, Kawadler JM, Aylett SE, Kirkham FJ, Clark CA. Arterial spin labeling characterization of cerebral perfusion during normal maturation from late childhood into adulthood: normal ‘reference range’ values and their use in clinical studies. J Cereb Blood Flow Metab 2014; 34: 776–84.
50. Adams RJ, Nichols FT, McKie V, McKie K, Milner P, Gammal TE. Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI. Neurology 1988; 38: 1012–17.
51. Hogan AMA, Cate I, Vargha-Khadem F, et al. Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction. Dev Sci 2006; 9: 379–87.
52. Prohovnik I, Pavlakis SG, Piomelli S, et al. Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology 1989; 39: 344–48.
53. Prohovnik I, Hurlet-Jensen A, Adams R, De Vivo D, Pavlakis SG. Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease. J Cereb Blood Flow Metab 2009; 29: 803–10.
54. Kirkham FFJ, Datta AKA. Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability. Dev Sci 2006; 9: 411–27.
55. Thompson RJ, Armstrong FD, Link CL, Pegelow CH, Moser F, Wang WC. A prospective study of the relationship over time of behavior problems, intellectual functioning, and family functioning in children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr Psychol 2003; 28: 59–65.
56. Platt OS, Rosenstock W, Espeland MA. Influence of sickle hemoglobinopathies on growth and development. N Engl J Med 1984; 311: 7–12.
57. Puffer ES, Schatz JC, Roberts CW. Relationships between somatic growth and cognitive functioning in young children with sickle cell disease. J Pediatr Psychol 2010; 35: 892-904.
58. Steen RG, Emudianughe T, Hunte M, et al. Brain volume in pediatric patients with sickle cell disease: evidence of volumetric growth delay? AJNR Am J Neuroradiol 2005; 26: 455–62.
59. Schatz J, Mcclellan CB. Sickle cell disease as a neurodevelopmental disorder. Ment Retard Dev Disabil Res Rev 2006; 12: 200–07.
60. Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA. Acute care utilization and rehospitalizations for sickle cell disease. JAMA 2010; 303: 1288–94.
61. McCavit TL, Xuan L, Zhang S, Flores G, Quinn CT. National trends in incidence rates of hospitalization for stroke in children with sickle cell disease. Pediatr Blood Cancer 2013; 60: 823–27.
62. Ballas SK, Gupta K, Adams-Graves P. Sickle cell pain: a critical reappraisal. Blood 2012; 120: 3647–56.
63. Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol 2011; 93: 385–404.
64. Gil KM, Carson JW, Porter LS, et al. Daily stress and mood and their association with pain, health-care use, and school activity in adolescents with sickle cell disease. J Pediatr Psychol 2003; 28: 363–73.
65. Frank N, Allison S, Cant M. Sickle Cell Disease. Cognitive Aspects of Chronic Illness in Children. New York, NY: Guilford, 1999: 172–89.
66. Tarazi RA, Grant ML, Ely E, Barakat LP. Neuropsychological functioning in preschool-age children with sickle cell disease: the role of illness-related and psychosocial factors. Child Neuropsychol 2007; 13: 155–72.
67. Moskowitz JT, Butensky E, Harmatz P, et al. Caregiving time in sickle cell disease: psychological effects in maternal caregivers. Pediatr Blood Cancer 2007; 48: 64–71.
68. Fowler M, Whitt J, Lallinger R, et al. Neuropsychologic and academic functioning of children with sickle cell anemia. J Dev Behav Pediatr 1988; 9: 213–20.
69. Fowler MG, Johnson MP, Atkinson SS. School achievement and absence in children with chronic health conditions. J Pediatr 1985; 106: 683–87.
70. Epping A, Myrvik M. Academic attainment findings in children with sickle cell disease. J Sch Health 2013; 83: 548–53.
71. Farber MD, Koshy M, Kinney TR. Cooperative Study of Sickle Cell Disease: demographic and socioeconomic characteristics of patients and families with sickle cell disease. J Chronic Dis 1985; 38: 495–505.
72. Boulet SL, Yanni EA, Creary MS, Olney RS. Health status and healthcare use in a national sample of children with sickle cell disease. Am J Prev Med 2010; 38: S528–35.
73. Wilker EH, Preis SR, Beiser AS, et al. Long-term exposure to fine particulate matter, residential proximity to major roads and measures of brain structure. Stroke 2015; 46: 1161–66.
74. Nevin R. How lead exposure relates to temporal changes in IQ, violent crime, and unwed pregnancy. Environ Res 2000; 83: 1–22.
75. Brink LL, Talbott EO, Sharma RK, et al. Do US ambient air lead levels have a significant impact on childhood blood lead levels: results of a national study. J Environ Public Health 2013; 2013: 278042.
76. Clark C, Crombie R, Head J, van Kamp I, van Kempen E, Stansfeld SA. Does traffic-related air pollution explain associations of aircraft and road traffic noise exposure on children's health and cognition? A secondary analysis of the United Kingdom sample from the RANCH project. Am J Epidemiol 2012; 176: 327–37.
77. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998; 339: 5–11.
78. Thornburg CD, Files BA, Luo Z, et al. Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood 2012; 120: 4304–10; quiz 4448.
79. Puffer E, Schatz J, Roberts CW. The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease. Child Neuropsychol 2007; 13: 142–54.
80. Marshall MJ, Bucks RS, Hogan AM, et al. Auto-adjusting positive airway pressure in children with sickle cell anemia: results of a phase I randomized controlled trial. Haematologica 2009; 94: 4–8.
81. White D, DeBaun M. Cognitive and behavioral function in children with sickle cell disease: a review and discussion of methodological issues. J Pediatr Hematol Oncol 1998; 20: 458–62.
82. Burgess PW, Alderman N, Forbes C, et al. The case for the development and use of ‘ecologically valid’ measures of executive function in experimental and clinical neuropsychology. J Int Neuropsychol Soc 2006; 12: 194–209.
83. Patel AB, Pathan HG. Quality of life in children with sickle cell hemoglobinopathy. Indian J Pediatr 2005; 72: 567–71.
84. Vichinsky E, Neumayr L, Gold J. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA 2010; 303: 1823–31.